Loading...

Novozymes A/S

NVZMY•PNK
Basic Materials
Chemicals - Specialty
$62.40
$-0.90(-1.42%)

Novozymes A/S (NVZMY) Stock Overview

Explore Novozymes A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap29B
P/E Ratio27.71
EPS (TTM)$1.42
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Week$72.83
1 Month$73.78
3 Months$68.82
1 Year Target$74.95

NVZMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novozymes A/S (NVZMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.28, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $74.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.71 and a market capitalization of 29B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.70%
5-Day Change
-8.04%
1-Month Change
-0.02%
3-Month Change
5.50%
6-Month Change
-14.87%
Year-to-Date (YTD) Change
3.04%
1-Year Change
7.54%
3-Year Change
-13.36%
5-Year Change
27.60%
All-Time (Max) Change
237.97%

Contact Information

https://www.novozymes.com
45 44 46 00 00
Krogshoejvej 36, Bagsvaerd, 2880

Company Facts

10,582 Employees
IPO DateJan 20, 2010
CountryDK
Actively Trading

Frequently Asked Questions

;